This new resource provides clear, simplified information on indication-, technology-, or company-specific upcoming data readouts and other clinical events. ARM has carefully curated all entries to ensure they fall within our narrowly defined criteria for regenerative medicines, and includes many milestones which are not reported in other clinical trial datasets, including anticipated product approvals.

Currently, the database includes 188 anticipated events and includes a search-and-download function, and results can be filtered by technology type, indication area, company, and/or rare disease status.

ARM will update and add entries quarterly and submissions are welcome

Please note: this tool is best viewed using Safari, Firefox, or Chrome web browsers.

To visit database

Share Button